Contact Dermatitis Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Contact Dermatitis - Pipeline Review, H1 2018, provides an overview of the Contact Dermatitis (Dermatology) pipeline landscape.
(EMAILWIRE.COM, April 04, 2018 ) Contact dermatitis is a type of skin inflammation that occurs when substances touching skin cause irritation or an allergic reaction. Signs and symptoms of contact dermatitis include red rash or bumps, dry, cracked, red patches, which may resemble a burn and pain or tenderness. There are two types of contact dermatitis; irritant and allergic. Irritant dermatitis, the most common type, is caused by contact with acids, alkaline materials such as soaps and detergents, fabric softeners, solvents, or other chemicals. The reaction usually looks like a burn. Allergic contact dermatitis is an itchy skin condition caused by an allergic reaction to allergen. Treatment includes oral corticosteroids and antihistamines to relieve intense itching.
Report Source: https://www.themarketreports.com/report/contact-dermatitis-pipeline-review-h1-2018
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Contact Dermatitis (Dermatology).
The pipeline guide reviews pipeline therapeutics for Contact Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Contact Dermatitis (Dermatology) therapeutics and enlists all their major and minor projects.
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036782
Reasons To Buy
Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Contact Dermatitis (Dermatology).
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Contact Dermatitis (Dermatology) pipeline depth and focus of Indication therapeutics.
Companies Mentioned
Brickell Biotech Inc
Dr. August Wolff GmbH & Co KG Arzneimittel
NeuroCycle Therapeutics GmbH
Novartis AG
Pfizer Inc
RaQualia Pharma Inc
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036782
Report Source: https://www.themarketreports.com/report/contact-dermatitis-pipeline-review-h1-2018
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Contact Dermatitis (Dermatology).
The pipeline guide reviews pipeline therapeutics for Contact Dermatitis (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Contact Dermatitis (Dermatology) therapeutics and enlists all their major and minor projects.
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036782
Reasons To Buy
Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Find and recognize significant and varied types of therapeutics under development for Contact Dermatitis (Dermatology).
Classify potential new clients or partners in the target demographic.
Develop tactical initiatives by understanding the focus areas of leading companies.
Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
Formulate corrective measures for pipeline projects by understanding Contact Dermatitis (Dermatology) pipeline depth and focus of Indication therapeutics.
Companies Mentioned
Brickell Biotech Inc
Dr. August Wolff GmbH & Co KG Arzneimittel
NeuroCycle Therapeutics GmbH
Novartis AG
Pfizer Inc
RaQualia Pharma Inc
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036782
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results